a month ago
PRTA
AnalystsCharles DuncanCharles Duncan's Stock Forecasts
AnalystsCharles Duncan
Analyst Ranking
Top 2%
#73 out of 4166 analysts
Average Return
+37.78%
Win Rate
41%27 out of 66
Risk vs Reward
Poor
Good
Charles Duncan's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Novavax IncNVAX | +2,273.26% | $9.50 | $225.46 | 2020-03-17 - 2021-03-17 | Strong Buy |
Cassava Sciences IncSAVA | +390.45% | $9.32 | $45.71 | 2020-10-23 - 2021-10-22 | Strong Buy |
Aimmune Therapeutics IncAIMT | +175.26% | $12.53 | $34.49 | 2020-03-23 - 2020-10-12 | Strong Buy |
Novavax IncNVAX | +169.36% | $64.75 | $174.41 | 2020-06-19 - 2021-06-18 | Strong Buy |
Biovie IncBIVI | +128.51% | $2.21 | $5.05 | 2022-07-22 - 2023-01-27 | Strong Buy |
Charles Duncan Analyst Color
Get additional color on Charles Duncan's coverage of popular stocks
2 months ago
FENC
7 months ago
AXSM
8 months ago
NVAX
Charles Duncan's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Prothena Corp Public Ltd CoPRTA | 2 | Strong Buy | $98.00 | +71.57% | Maintains | a month ago |
Anavex Life Sciences CorpAVXL | 2 | Hold | $11.00 | +4.17% | Downgrades | 2 months ago |
Fennec Pharmaceuticals IncFENC | 2 | Strong Buy | $12.00 | +26.85% | Upgrades | 2 months ago |
Neurocrine Biosciences IncNBIX | 1 | Strong Buy | $132.00 | +21.94% | Maintains | 3 months ago |
Cognition Therapeutics IncCGTX | 1 | Strong Buy | $12.00 | +494.06% | Initiates Coverage On | 4 months ago |
Cerevel Therapeutics Holdings IncCERE | 1 | Strong Buy | $41.00 | +19.08% | Initiates Coverage On | 4 months ago |
Vaxart IncVXRT | 2 | Strong Buy | $8.00 | +620.72% | Maintains | 5 months ago |
Biovie IncBIVI | 1 | Strong Buy | $7.00 | +38.61% | Initiates Coverage On | 6 months ago |
Axsome Therapeutics IncAXSM | 4 | Strong Buy | $64.00 | -8.92% | Maintains | 7 months ago |
Acadia Pharmaceuticals IncACAD | 6 | Strong Buy | $26.00 | +40.01% | Maintains | 7 months ago |
Novavax IncNVAX | 6 | Strong Buy | $168.00 | +1,388.04% | Maintains | 8 months ago |
Stoke Therapeutics IncSTOK | 1 | Strong Buy | $38.00 | +294.60% | Maintains | 8 months ago |
Harmony Biosciences Holdings IncHRMY | 1 | Strong Buy | $63.00 | +29.71% | Initiates Coverage On | 10 months ago |
Aptinyx IncAPTX | 1 | Strong Buy | $5.00 | +1,090.48% | Maintains | 10 months ago |
Oramed Pharmaceuticals IncORMP | 1 | Strong Buy | $20.00 | +930.93% | Initiates Coverage On | a year ago |
Vtv Therapeutics IncVTVT | 2 | Strong Buy | $5.00 | +405.05% | Initiates Coverage On | a year ago |
Bionomics LimitedBNOX | 1 | Strong Buy | $52.00 | N/A | Initiates Coverage On | a year ago |
Cardiol Therapeutics IncCRDL | 1 | Strong Buy | $8.00 | N/A | Initiates Coverage On | a year ago |
Lucid Diagnostics IncLUCD | 1 | Strong Buy | $21.00 | N/A | Initiates Coverage On | a year ago |
Biohaven Pharmaceutical Holding Co LtdBHVN1 | 4 | Strong Buy | $165.00 | N/A | Maintains | a year ago |
Cybin IncCYBN | 1 | Strong Buy | $9.00 | N/A | Initiates Coverage On | a year ago |
Atai Life Sciences NvATAI | 1 | Strong Buy | $45.00 | N/A | Initiates Coverage On | 2 years ago |
Seelos Therapeutics IncSEEL | 1 | Strong Buy | $10.00 | N/A | Initiates Coverage On | 2 years ago |
Clene IncCLNN | 1 | Strong Buy | $22.00 | N/A | Initiates Coverage On | 2 years ago |
Ovid Therapeutics IncOVID | 1 | Hold | $4.00 | N/A | Downgrades | 2 years ago |
Lumos Pharma IncLUMO | 1 | Strong Buy | $32.00 | N/A | Initiates Coverage On | 2 years ago |
Cassava Sciences IncSAVA | 1 | Strong Buy | $24.00 | N/A | Initiates Coverage On | 2 years ago |
Inovio Pharmaceuticals IncINO | 5 | Hold | $12.00 | N/A | Downgrades | 2 years ago |
Prevail Therapeutics IncPRVL | 1 | Strong Buy | $26.00 | N/A | Initiates Coverage On | 2 years ago |
Geron CorpGERN | 1 | Strong Buy | $4.00 | N/A | Maintains | 3 years ago |
Halozyme Therapeutics IncHALO | 2 | Strong Buy | $39.00 | N/A | Reiterates | 3 years ago |
Cara Therapeutics IncCARA | 1 | Strong Buy | $34.00 | N/A | Reiterates | 3 years ago |
Cytokinetics IncCYTK | 1 | Strong Buy | $23.00 | N/A | Reiterates | 3 years ago |
Aimmune Therapeutics IncAIMT | 2 | Strong Buy | $32.00 | N/A | Maintains | 3 years ago |
Reata Pharmaceuticals IncRETA | 2 | Strong Buy | $320.00 | N/A | Reiterates | 3 years ago |
Intra Cellular Therapies IncITCI | 3 | Strong Buy | $47.00 | N/A | Reiterates | 3 years ago |
Catalyst Pharmaceuticals IncCPRX | 1 | Strong Buy | $12.00 | N/A | Reiterates | 3 years ago |
Adamas Pharmaceuticals IncADMS | 1 | Hold | $7.00 | N/A | Reiterates | 3 years ago |
Corcept Therapeutics IncCORT | 3 | Hold | $14.00 | N/A | Downgrades | 4 years ago |
Vanda Pharmaceuticals IncVNDA | 1 | Hold | $26.00 | N/A | Initiates Coverage On | 4 years ago |
Acorda Therapeutics IncACOR | 1 | Hold | $32.00 | N/A | Initiates Coverage On | 4 years ago |
Sangamo Therapeutics IncSGMO | 1 | Strong Buy | N/A | N/A | Upgrades | 5 years ago |
Altimmune IncALT | 1 | Strong Buy | $6.00 | N/A | Initiates Coverage On | 5 years ago |
Zynerba Pharmaceuticals IncZYNE | 1 | Strong Buy | N/A | N/A | Upgrades | 5 years ago |
Pdl Biopharma IncPDLI | 1 | Strong Buy | $4.00 | N/A | Reinstates | 6 years ago |
©2023 WallStreetZen
Company
AboutBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.